Logo-jrip

Indexing Information

Scupos

Member of

Follower of





 

J Renal Inj Prev. 2019;8(1): 1-5. doi: 10.15171/jrip.2019.01

Review

The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy

Farhad Gholami 1, Ali Ghasemi 2, Ahmad Reza Bahrami 3, Hamid Reza Bidkhouri 3, Hojat Naderi Mishkin 4, Masoud Pezeshki Rad 5, Farzaneh Sharifipour 6 *

Cited by CrossRef: 4

1- Taghdiri Nooshabadi V, Verdi J, Ebrahimi-Barough S, Mowla J, Atlasi M, Mazoochi T, Valipour E, Shafiei S, Ai J, Banafshe H. Endometrial Mesenchymal Stem Cell-Derived Exosome Promote Endothelial Cell Angiogenesis in a Dose Dependent Manner: A New Perspective on Regenerative Medicine and Cell-Free Therapy. Arch Neurosci. 2019;6(4) [Crossref]
2- Zhang L, Lai X, Guo Y, Ma J, Fang J, Li G, Xu L, Yin W, Chen Z. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study. Renal Failure. 2021;43(1):1266 [Crossref]
3- Khalili P, Maddah R, Maleknia M, Shateri Amiri B, Forouzani F, Hasanvand A, Rezaeeyan H. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach. Mol Biotechnol. 2023;65(8):1275 [Crossref]
4- Beheshti Monfared M, Ghaderi H, Ansari Aval Z, Hekmat M, Mirjafari S, Beheshtimonfared R. Can the Left Internal Mammary Artery Be Used During Coronary Artery Bypass Graft Surgery in Patients Undergoing Bone Marrow Transplant? A First Case Report. Int J Cancer Manag. 2023;16(1) [Crossref]